The Center for Immunotherapy at Roswell Park Cancer Institute has launched a phase I clinical research study of a dendritic cell vaccine designed to both eradicate cancer cells and prevent disease relapse. You can read more about this new vaccine and clinical trial here: goo.gl


Like this post? Subscribe to my RSS feed and get loads more!